Table 8.
Potency (nM) | |||||
---|---|---|---|---|---|
Structural class | Compound | Cell type | IC50 | EC50 | Selectivity tests |
5‐Methoxysoralen | 9 170, 171 | L929 cells stably expressing KV1.3; manual whole‐cell patch‐clamp | ‐ | 100,000 | No selectivity |
Psora‐4 | 9b 170, 171 | ‐ | 3 | Lacking selectivity over KV1.5 (EC50 = 8 nM), 17‐ to 70‐fold selectivity over Kv1x family channels | |
PAP‐1 | 9c 170, 171 | ‐ | 2 | 23‐fold selectivity over KV1.5 | |
Furoquinoline | 9d 172 | L929 cells expressing KV1.3; whole‐cell patch‐clamp | 150 | ‐ | Threefold selectivity over KV1.5 |
Acridinone | 9e 172 | 165 | ‐ | Threefold selectivity over KV1.5 | |
Furochromene‐7‐thione | 9f 172 | 17 | ‐ | 22‐fold selectivity over KV1.5 | |
Clofazimine | 10 173, 174 | Jurkat T cells | 300 | ‐ | Moderate selectivity over KV1.1, KV1.2, KV1.5, and KV3.1 (10 µM: ≤ 50% inhibition) |
Diphenoxylate | 11 175 | L929 cells expressing KV1.3; manual whole‐cell patch‐clamp | 5000 | ‐ | Not tested |
Diphenoxylate analog | 11a 175 | 750 | ‐ |